Find below videos and webinars on myeloma. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
Videos and webinars on myeloma
EHA 2023 | MagnetisMM 3 clinical trial
Prof. Dr. Mohamad Mohty, Professor and Head of the hematology and cellular therapy department at the Saint-Antoine Hospital in Paris, France, explains the latest MagnetisMM-3 clinical trial information at the ...European Hematology Association hybrid congress 2023. This clinical trial tests the efficacy of elranatamab in relapsed and refractory myeloma.[+] Show More
EHA 2023 | MagnetisMM 3 clinical trial
Prof. Dr. Mohamad Mohty, Professor and Head of the hematology and ...
Webinar | Patient and haematologist perspectives on Minimal Residual Disease testing in myeloma
Recording of the MPE webinar "Patient and haematologist perspectives ...
CARAMBA interview: manufacturing process (GER)
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
CARAMBA interview: manufacturing process (EN)
Prof. Dr. Halvard B. Bönig, Research and Development Department ...
CARAMBA interview: CARAMBA clinical trial updates on safety (FR)
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
CARAMBA interview: CARAMBA clinical trial updates on safety (EN)
Prof. Dr. Ibrahim Yakoub-Agha, Head of the Hematopoietic Cell ...
CARAMBA interview: immune monitoring (ES)
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
CARAMBA interview: immune monitoring (EN)
Dr. Bruno Paiva, Scientific Coordinator of the Diagnostic Laboratories ...
Webinar | Doctor and patients' perspective on myeloma CAR-T
Recording of the webinar organised by Myeloma Patients Europe (MPE) on ...
ASH 22 | myeloma highlights
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
ASH22 | Bispecific antibodies updates
In this video, Dr Charlotte Pawlyn, Haematology Consultant, Royal ...
ASH 22 | Dr Hajek's meeting highlights
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, ...
ASH 22 | Dr Dimopoulos' perspective on the myeloma highlights presented at ASH 2022
Dr Meletios Dimopoulos, Chairman of the Department of Clinical ...
ASH 22 | COVID-19 updates
COVID-19, and how it affects to myeloma and AL amyloidosis patients, ...
ASH 22 | Myeloma XI clinical trial
Lenalidomide maintenance after autologous stem cell transplant (ASCT) ...
1
of 8
Subscribe to
our newsletter!